Eli Gilboa

25.1k total citations · 7 hit papers
183 papers, 20.0k citations indexed

About

Eli Gilboa is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Eli Gilboa has authored 183 papers receiving a total of 20.0k indexed citations (citations by other indexed papers that have themselves been cited), including 110 papers in Molecular Biology, 110 papers in Immunology and 56 papers in Genetics. Recurrent topics in Eli Gilboa's work include Immunotherapy and Immune Responses (91 papers), RNA Interference and Gene Delivery (61 papers) and Virus-based gene therapy research (54 papers). Eli Gilboa is often cited by papers focused on Immunotherapy and Immune Responses (91 papers), RNA Interference and Gene Delivery (61 papers) and Virus-based gene therapy research (54 papers). Eli Gilboa collaborates with scholars based in United States, Israel and Germany. Eli Gilboa's co-authors include Smita K. Nair, David Boczkowski, Bruce A. Sullenger, Johannes Vieweg, David J. Snyder, David Baltimore, Angel Porgador, H. Kim Lyerly, Rajat Bannerji and Stephen P. Goff and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Eli Gilboa

181 papers receiving 19.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras

2006 812 citations Eli Gilboa et al. Nature Biotechnology profile →
Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.

1996 761 citations David Boczkowski, Smita K. Nair et al. The Journal of Experimental Medicine profile →
A detailed model of reverse transcription and tests of crucial aspects

1979 539 citations Eli Gilboa et al. profile →
Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.

1990 511 citations Bernd Gänsbacher, Rajat Bannerji et al. The Journal of Experimental Medicine profile →
Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors

1985 494 citations Eli Gilboa et al. profile →
Structure of the Abelson murine leukemia virus genome and the homologous cellular gene: Studies with cloned viral DNA

1980 418 citations Eli Gilboa et al. profile →
Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target

2018 287 citations Brett Schrand, Shouhao Zhou et al. Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eli Gilboa United States	76	11.5k	10.5k	6.0k	5.0k	1.3k	183	20.0k
Philip D. Greenberg United States	74	4.5k 0.4×	15.2k 1.5×	11.4k 1.9×	3.6k 0.7×	1.3k 1.0×	246	22.5k
Richard A. Morgan United States	53	7.0k 0.6×	8.1k 0.8×	13.3k 2.2×	6.5k 1.3×	393 0.3×	124	18.7k
W. Martin Kast United States	72	6.2k 0.5×	13.0k 1.2×	4.8k 0.8×	1.9k 0.4×	672 0.5×	280	18.2k
James L. Riley United States	67	4.1k 0.4×	12.3k 1.2×	9.7k 1.6×	2.5k 0.5×	1.3k 1.0×	149	18.8k
R. Michael Blaese United States	70	6.8k 0.6×	5.1k 0.5×	4.2k 0.7×	7.6k 1.5×	392 0.3×	238	16.7k
Philippe Kourilsky France	65	5.0k 0.4×	10.6k 1.0×	2.7k 0.4×	2.1k 0.4×	598 0.5×	240	16.1k
Walter J. Storkus United States	66	5.6k 0.5×	12.9k 1.2×	6.3k 1.0×	1.9k 0.4×	281 0.2×	249	16.3k
Cornelis J.M. Melief Netherlands	75	7.0k 0.6×	17.7k 1.7×	8.8k 1.5×	1.7k 0.3×	477 0.4×	233	22.4k
Donald B. Kohn United States	69	9.8k 0.9×	3.1k 0.3×	3.6k 0.6×	7.8k 1.6×	1.1k 0.8×	361	16.0k
Michael B. Mathews United States	71	14.5k 1.3×	2.6k 0.2×	2.3k 0.4×	4.6k 0.9×	1.3k 1.0×	195	19.1k

Countries citing papers authored by Eli Gilboa

Since Specialization

Citations

This map shows the geographic impact of Eli Gilboa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Gilboa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Gilboa more than expected).

Fields of papers citing papers by Eli Gilboa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Gilboa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Gilboa. The network helps show where Eli Gilboa may publish in the future.

Co-authorship network of co-authors of Eli Gilboa

This figure shows the co-authorship network connecting the top 25 collaborators of Eli Gilboa. A scholar is included among the top collaborators of Eli Gilboa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli Gilboa. Eli Gilboa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Gilboa, Eli, David Boczkowski, & Smita K. Nair. (2022). The Quest for mRNA Vaccines. Nucleic Acid Therapeutics. 32(6). 449–456.

2.

Garrido, Greta, Brett Schrand, Agata Levay, et al.. (2020). Vaccination against Nonmutated Neoantigens Induced in Recurrent and Future Tumors. Cancer Immunology Research. 8(7). 856–868. 8 indexed citations

3.

Garrido, Greta, Brett Schrand, Ailem Rabasa, et al.. (2019). Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity. Nature Communications. 10(1). 3773–3773. 50 indexed citations

4.

Schrand, Brett, Agata Levay, Iris Castro, et al.. (2017). Radiation-Induced Enhancement of Antitumor T-cell Immunity by VEGF-Targeted 4-1BB Costimulation. Cancer Research. 77(6). 1310–1321. 30 indexed citations

5.

Schrand, Brett, Alexey Berezhnoy, Randall Brenneman, et al.. (2014). Targeting 4-1BB Costimulation to the Tumor Stroma with Bispecific Aptamer Conjugates Enhances the Therapeutic Index of Tumor Immunotherapy. Cancer Immunology Research. 2(9). 867–877. 72 indexed citations

6.

Puijvelde, Gijs H.M. van, Amanda C. Foks, Kim L. L. Habets, et al.. (2009). Vaccination against Foxp3+ regulatory T cells aggravates atherosclerosis. Atherosclerosis. 209(1). 74–80. 59 indexed citations

7.

Su, Zhen, Jens Dannull, Benjamin Yang, et al.. (2005). Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer. The Journal of Immunology. 174(6). 3798–3807. 273 indexed citations

8.

Kavanagh, Daniel G., Daniel E. Kaufmann, Sherzana Sunderji, et al.. (2005). Expansion of HIV-specific CD4+ and CD8+ T cells by dendritic cells transfected with mRNA encoding cytoplasm- or lysosome-targeted Nef. Blood. 107(5). 1963–1969. 52 indexed citations

9.

Abdel-Wahab, Zeinab, Jens Dannull, Smita K. Nair, et al.. (2004). Induction of Human Dendritic Cell Maturation Using Transfection with RNA Encoding a Dominant Positive Toll-Like Receptor 4. The Journal of Immunology. 172(11). 7162–7168. 52 indexed citations

10.

Nair, Smita K., C. McLaughlin, Alon Z. Weizer, et al.. (2003). Injection of Immature Dendritic Cells into Adjuvant-Treated Skin Obviates the Need for Ex Vivo Maturation. The Journal of Immunology. 171(11). 6275–6282. 134 indexed citations

11.

Heiser, Axel, Doris Coleman, Jens Dannull, et al.. (2002). Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. Journal of Clinical Investigation. 109(3). 409–417. 23 indexed citations

12.

Heiser, Axel, Doris Coleman, Jens Dannull, et al.. (2002). Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. Journal of Clinical Investigation. 109(3). 409–417. 419 indexed citations

13.

Faiola, Brenda, Carolyn A. Doyle, Eli Gilboa, & Smita K. Nair. (2002). Influence of CD4 T cells and the source of major histocompatibility complex class II‐restricted peptides on cytotoxic T‐cell priming by dendritic cells. Immunology. 105(1). 47–55. 11 indexed citations

14.

Heiser, Axel, Margaret A. Maurice, Donna Yancey, et al.. (2001). Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA. The Journal of Immunology. 166(5). 2953–2960. 165 indexed citations

15.

Kodaira, Yuzo, Smita K. Nair, Lucile E. Wrenshall, Eli Gilboa, & Jeffrey L. Platt. (2000). Phenotypic and Functional Maturation of Dendritic Cells Mediated by Heparan Sulfate. The Journal of Immunology. 165(3). 1599–1604. 97 indexed citations

16.

Gilboa, Eli, Smita K. Nair, & H. Kim Lyerly. (1998). Immunotherapy of cancer with dendritic-cell-based vaccines. Cancer Immunology Immunotherapy. 46(2). 82–87. 240 indexed citations

17.

Nair, Smita K., David Boczkowski, Michael Morse, et al.. (1998). Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nature Biotechnology. 16(4). 364–369. 335 indexed citations

18.

Nair, Smita K., David J. Snyder, & Eli Gilboa. (1996). Cells treated with TAP-2 antisense oligonucleotides are potent antigen-presenting cells in vitro and in vivo. The Journal of Immunology. 156(5). 1772–1780. 10 indexed citations

19.

Connor, James R., Rajat Bannerji, Shigeru Saito, et al.. (1993). Regression of bladder tumors in mice treated with interleukin 2 gene-modified tumor cells.. The Journal of Experimental Medicine. 177(4). 1127–1134. 166 indexed citations

20.

Gastl, Guenther, Connie L. Finstad, Anna Guarini, et al.. (1992). Retroviral vector-mediated lymphokine gene transfer into human renal cancer cells.. PubMed. 52(22). 6229–36. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact